Related Experiment Video
Updated: Jul 3, 2026
06:55
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Simultaneous detection of six human diarrheal pathogens by using DNA microarray combined with tyramide signal
Dazhi Jin1, Hongjuan Qi, Suhong Chen
1Beijing Institute of Radiation Medicine, No. 27 Taiping road, Beijing, China. dazhijin_y@hotmail.com
Journal of Microbiological Methods
|July 29, 2008
Summary
A new diagnostic method combines multiplex PCR and DNA microarray with tyramide signal amplification (TSA) for rapid detection of six common diarrheal pathogens. This sensitive and specific assay accurately identifies specific strains and serotypes in clinical samples.
Area of Science:
- Microbiology
- Molecular Biology
- Clinical Diagnostics
Background:
- Diarrheal diseases pose a significant global health burden, necessitating rapid and accurate etiological diagnosis.
- Conventional diagnostic methods for gastrointestinal pathogens are often time-consuming and lack multiplexing capabilities.
- Distinguishing between specific strains and serotypes of pathogens is crucial for effective treatment and epidemiological surveillance.
Purpose of the Study:
- To develop and validate a novel multiplex assay for the simultaneous detection of six key human diarrheal pathogens.
- To enhance the sensitivity and specificity of pathogen detection using tyramide signal amplification (TSA).
- To enable differentiation of specific serotypes for pathogens like Vibrio cholera and Escherichia coli O157:H7.
Main Methods:
- Integration of multiplex PCR (Polymerase Chain Reaction) with DNA microarray technology.
- Application of tyramide signal amplification (TSA) to improve signal detection.
- Validation using clinical specimens and mocked double-blind samples.
Main Results:
- Simultaneous detection of six human diarrheal pathogens: Yersinia enterocolitica, Shigella spp, Salmonella typhi, Brucella spp, Vibrio cholera, and Escherichia coli O157:H7.
- High specificity (100%) for target pathogens and ability to differentiate V. cholera serotypes (O1 vs. O139) and E. coli O157:H7 strains.
- Achieved a limit of detection of approximately 10^3 CFU/mL.
- Demonstrated high concordance with conventional assays (98.6% for clinical specimens, 100% for double-blind samples).
Conclusions:
- The developed multiplex PCR-DNA microarray assay combined with TSA is a sensitive and specific tool for diagnosing multiple human diarrheal pathogens.
- This method offers a reliable platform for clinical diagnostics and public health surveillance of infectious diarrheal diseases.
- The assay's ability to differentiate specific strains and serotypes enhances its utility in clinical and epidemiological settings.
